Know Your Thyroid
The Gland That
Governs Everything.
A butterfly-shaped gland the size of a walnut controls your metabolism, your heart rate, your body temperature, your brain, your mood, your hair, your menstrual cycle. When it goes wrong — and in women it goes wrong far more often than in men — it goes wrong slowly. Quietly. In ways that medicine has spent decades attributing to something else.
Thyroid disorders are the most common endocrine condition in the world. Hypothyroidism — an underactive thyroid — is diagnosed at 498 cases per 100,000 women per year in Western countries. The equivalent figure for men is 2.2. That is not a misprint. The difference is not explained by sampling bias or reporting differences. It reflects a genuine biological reality: the thyroid is, in a specific and profound sense, a female organ. And the medical system that manages thyroid disease has not fully reckoned with what that means.
Hashimoto's thyroiditis — the autoimmune condition in which the immune system attacks and progressively destroys thyroid tissue — is the most common autoimmune disease in the world and the primary cause of hypothyroidism in countries where dietary iodine is adequate. It is at least ten times more common in women than in men. It typically presents in the reproductive years — most commonly between 30 and 50 — at exactly the ages when women are most likely to have their fatigue, brain fog, weight changes, and mood symptoms attributed to work stress, motherhood, anxiety, or depression.
This post is about what the thyroid actually does, what goes wrong when it underperforms, how the diagnostic framework for detecting that underperformance has a structural problem that parallels the ferritin reference range problem, and why it takes so many women so many years and so many doctors to get a diagnosis that the evidence was pointing toward for much of that time.
What the Thyroid Actually Governs
Click any function to see what T3 and T4 do — and what goes wrong before a blood test shows anything
The thyroid gland produces two hormones: thyroxine (T4), which makes up approximately 90% of thyroid output, and triiodothyronine (T3), which accounts for the remaining 10% but is many times more biologically active. T4 is essentially a prohormone — it circulates in the blood until enzymes in peripheral tissues (primarily the liver, kidneys, brain, and muscles) convert it into active T3 by removing one iodine atom. T3 then enters cells, binds to nuclear receptors, and directly regulates gene expression — governing how fast cells use energy, how fast the heart beats, how effectively the brain processes information, and dozens of other processes simultaneously.
The production of T3 and T4 is controlled by a negative feedback loop: the pituitary gland releases TSH (thyroid-stimulating hormone) to tell the thyroid to produce more hormone. When thyroid hormone levels are adequate, TSH falls. When they are too low, TSH rises. This is why TSH is used as the primary screening test for thyroid dysfunction: a high TSH suggests the pituitary is compensating for insufficient thyroid output; a low TSH suggests the opposite. It is an elegant system. It is also, as we will see, a system whose diagnostic threshold has a problem very similar to the ferritin reference range problem — one that means significant thyroid dysfunction can be present for years before a blood result triggers clinical action.
Autoimmune thyroid disease is at least ten times more common in women. Hypothyroidism has an estimated incidence of 498.4 per 100,000 per year in women and 2.2 per 100,000 per year in men in Western countries — a ratio that makes it one of the most starkly sex-skewed conditions in medicine. Hashimoto's thyroiditis and Graves' disease — the two most common autoimmune thyroid conditions — are both predominantly female, and both involve the production of anti-thyroid antibodies. Autoimmune thyroiditis accounts for 55–65% of all female hypothyroidism cases. The sex difference appears to be driven by the interaction between estrogen, the X chromosome (which carries immune regulatory genes women have two copies of), and the fundamental immunological differences between male and female biology. [1,2]
Estrogen, pregnancy, and perimenopause are the three primary hormonal triggers for onset. Thyroid disorders in women most commonly emerge at three life stages: puberty (when estrogen first begins modulating immune function), pregnancy and the postpartum period (when profound immune recalibration occurs), and perimenopause (when declining estrogen destabilises immune regulation). Postpartum thyroiditis — a transient autoimmune inflammation of the thyroid — affects 5–10% of women after delivery and is often missed entirely, with its fatigue, mood symptoms, and brain fog attributed entirely to new parenthood. Pregnancy itself increases demand on the thyroid by 40–100%, and undetected hypothyroidism during pregnancy is associated with increased miscarriage risk, impaired foetal neurological development, and maternal complications. [2]
Thyroid hormone directly regulates cortical circuits and brain function. A 2024 study published in Cell established that thyroid hormone directly activates cell-type-specific transcriptional programmes in the frontal cortex — regulating axon-guidance genes in glutamatergic neurons, synaptic regulatory genes in both neurons and astrocytes, and myelination factors in oligodendrocytes. In the brain, T4 is converted to active T3 by type 2 deiodinase in astrocytes, which then regulates synaptic glutamate clearance. The cognitive symptoms of hypothyroidism — slow thinking, poor memory, difficulty concentrating, word-finding difficulty — are not vague or psychosomatic. They are the direct neurological consequence of insufficient thyroid hormone at the level of synaptic regulation and cortical circuit function. [3]
Subclinical hypothyroidism affects 6–10% of women — and is often untreated. Subclinical hypothyroidism is defined as an elevated TSH with normal T4 levels. It affects an estimated 6–10% of women and 2–4% of men. Symptoms include fatigue, weight gain, cold intolerance, hair loss, brain fog, muscle weakness, and menstrual irregularities — the full hypothyroid symptom picture, in many cases — but because T4 is normal, treatment decisions are contested. Current guidelines generally recommend treatment when TSH exceeds 10 mIU/L; for TSH between 4.5 and 10 mIU/L, the recommendation is controversial. Subclinical hypothyroidism is associated with increased cardiovascular risk, adverse pregnancy outcomes, and measurably lower quality of life. Whether to treat is not an academic debate — for the women living with those symptoms, it is a clinical urgency. [4]
The thyroid is not a gender-neutral organ that happens to go wrong more often in women. It is an organ whose function is directly intertwined with the female hormonal system — and that intertwining has never been adequately incorporated into how thyroid disease is diagnosed or managed.
The TSH Problem
Drag the slider to explore what the same TSH result means — and why "normal" is not the same as "optimal for you"
Hashimoto's thyroiditis does not arrive fully formed. It develops over months and years through a progression of stages — each with a distinct biological reality, a distinct symptom profile, and a distinct likelihood of being detected by standard testing. Understanding the progression is the difference between a diagnosis at Stage 1 and a diagnosis at Stage 4 — which, for many women, is the difference between being diagnosed in their thirties and being diagnosed in their forties.
The Hashimoto's Progression
Click each stage to see what is happening — and what the standard blood test shows at that point
TSH alone is the screening test. It is a useful starting point but an insufficient endpoint. A complete picture requires: TSH, Free T4, Free T3 (the active hormone), and — critically if you have symptoms — TPO antibodies (anti-thyroid peroxidase) and anti-thyroglobulin antibodies. Elevated antibodies in the presence of normal TSH indicates Hashimoto's is active. Many clinicians do not routinely order antibodies unless TSH is abnormal. Ask explicitly.
A TSH of 4.2 is "within range." It is also at the high end of a range that spans a 10-fold variation. If your previous TSH was consistently 1.0–1.5 and it is now 4.2, your thyroid output has dropped significantly even though both values are "normal." Tracking your TSH trend over time — not just comparing each result to the reference range — is more clinically informative. Many endocrinologists consider a TSH above 2.5 to be worth investigating in symptomatic women, particularly those with positive antibodies.
Thyroid peroxidase — the enzyme that makes thyroid hormones — requires iron to function. Iron deficiency reduces TPO activity, impairing thyroid hormone synthesis even when TSH and T4 appear normal. Iron deficiency also increases the risk of developing TPO antibodies — raising autoimmune thyroid disease risk. A thyroid workup without an iron panel is incomplete. If you have Hashimoto's, iron status (specifically serum ferritin, with an evidence-based threshold of 50 ng/mL) should be assessed and optimised as part of management.
The three highest-risk windows for thyroid onset are puberty, the postpartum period (3–6 months after delivery), and perimenopause — all moments of significant estrogen change and immune recalibration. Postpartum thyroiditis in particular is chronically underdiagnosed: its fatigue and mood symptoms are almost universally attributed to new parenthood rather than investigated. If you have a family history of thyroid disease, autoimmune conditions, or experienced significant fatigue or mood changes in any of these three windows, this warrants a full thyroid panel including antibodies.
The gland is the size of a walnut. It sits at the front of your throat, shaped like a butterfly. Every cell in your body has a receptor for what it makes. When it slows — gradually, quietly, over months or years — everything slows with it. Your metabolism, your heart rate, your body temperature, your gut, your hair follicles, your cognitive processing, your mood. All of it. Simultaneously. Slowly enough that each individual symptom can be attributed to something else. Stress. Age. Not sleeping well. Needing to exercise more. Anxiety.
A butterfly-shaped gland. A 200-fold difference in diagnosis rates between women and men. An average of five to seven doctors before a diagnosis. Years of bloodwork returned as normal while antibodies accumulated and tissue was destroyed. This is not a mystery. It is a consequence of a diagnostic system that was not designed to look for this problem in this body at this pace.
Know your thyroid numbers. Know what "normal" was built from. Know the difference between a population reference range and your individual setpoint. Know to ask for antibodies, not just TSH. And know that the thyroid symptoms that have been attributed to everything except your thyroid for years may have been telling the truth all along.
Your thyroid deserves better. Love, Nina ❤References
- Sategna-Guidetti, C., et al. (1994). Thyroid autoimmunity and female gender. Clinical & Experimental Immunology, 23(1). https://pubmed.ncbi.nlm.nih.gov/8320432/
- CME Geriatric Medicine. (2025). The etiology of hypothyroidism in females: Systematic review. https://www.cmegeriatricmed.co.uk
- Broberger, C., et al. (2024). Thyroid hormone remodels cortex to coordinate body-wide metabolism and exploration. Cell, 187(17). https://doi.org/10.1016/j.cell.2024.07.009
- Biondi, B., & Cooper, D. S. (2019). Subclinical hypothyroidism: When to treat. Cleveland Clinic Journal of Medicine, 86(2), 101–110. https://doi.org/10.3949/ccjm.86a.17053
- Gierach, M., et al. (2024). Iron and ferritin deficiency in women with hypothyroidism and chronic lymphocytic thyroiditis. Endokrynologia Polska, 75(3), 253–261. https://doi.org/10.5603/ep.97860